In ovalbumin (OVA)-induced asthma mouse models, SCFAs have been shown to decrease levels of CD4+ T cells and IgE following vancomycin treatment, which results in alleviated AHR and reduced airway inflammation [51]. The gene discussed is IGHE; the disease is asthma.